Tags

,

GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week’s decision to trade more than $20 billion of assets with Swiss rival Novartis



from NYT > Business Day http://ift.tt/1iCfG1Z
via IFTTThttp://ift.tt/R2ncgF http://ift.tt/IP98QF